Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Holter Monitoring in BPH and IHD Patients
NCT03856242Phase 4Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of tamsulosin in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Sechenov First Moscow State Medical University. Primary endpoint: Changes in 24-hour ECG monitoring parameters at 1 month. Started Sep 2015; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT03856242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856242.